Company Analysis
Sign in

Vaxcyte, Inc. (PCVX)

Nasdaq: PCVX · Biological Products, (No Diagnostic Substances) · San Carlos, CA · filing with the SEC since 2015
Full chart Alerts Compare
Grade5.0
◀ Past 5.3● Present 6.2▶ Future 3.7
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Patents

US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026

7 patents granted to the 4 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Vaxcyte, Inc.’s names, not what it holds today.

Patents granted
7
7 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 3 in 2024 and 1 in 2023
Applications published
16
2 of them in 2025
Names they are printed under
4
its own name, a former name
By yearGrantedApplications published
'18'19'20'21'22'23'24'25
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
Pharmaceuticals6
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name4 counted
Vaxcyte, Inc. its own name
named as the applicant on its applications, in US
0 granted
12 published
Vaxcyte, Inc. its own name
US, as the owner printed on each patent
7 granted
1 published
SUTROVAX, INC. a former name
US, as the owner printed on each patent
0 granted
2 published
SUTROVAX, INC. a former name
named as the applicant on its applications, in US
0 granted
1 published
Newest grantseach row opens the USPTO’s own copy
GrantedPatentTitleFieldOwner as printed
Apr 22, 202512,280,097Optimized cell-free synthesis of invasion plasmid antigen B and related compositions and methods of usePharmaceuticalsVaxcyte, Inc.
Mar 18, 202512,252,454Carrier-protein polysaccharide conjugation methodsPharmaceuticalsVaxcyte, Inc.
Oct 22, 202412,121,575Periodontitis vaccine and related compositions and methods of usePharmaceuticalsVaxcyte, Inc.
Jun 4, 202411,998,599Polypeptide-antigen conjugates with non-natural amino acidsPharmaceuticalsVaxcyte, Inc.
Apr 9, 202411,951,165Conjugated vaccine carrier proteinsPharmaceuticalsVaxcyte, Inc.
Jul 18, 202311,701,414Periodontitis vaccine and related compositions and methods of usePharmaceuticalsVaxcyte, Inc.
Nov 17, 202010,835,590Periodontitis vaccine and related compositions and methods of usePharmaceuticalsVaxcyte, Inc.
Newest applications publishedan application is a clue, never a plan
PublishedApplicationTitleFieldOwner as printed
Aug 28, 20252025/0269004ENTEROCOCCUS FAECALIS VACCINE AND USES THEREOFPharmaceuticalsVaxcyte, Inc.
Jul 3, 20252025/0214912CARRIER-PROTEIN POLYSACCHARIDE CONJUGATION METHODSPharmaceuticalsVaxcyte, Inc.
Oct 31, 20242024/0358823CONJUGATED VACCINE CARRIER PROTEINSPharmaceuticalsVaxcyte, Inc.
Oct 17, 20242024/0342274POLYPEPTIDE-ANTIGEN CONJUGATES WITH NON-NATURAL AMINO ACIDSPharmaceuticalsVaxcyte, Inc.
Oct 10, 20242024/0335521STABILIZATION OF ADJUVANTED VACCINE COMPOSITIONS AND THEIR USEPharmaceuticalsVaxcyte, Inc.
Jul 11, 20242024/0226259PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USEPharmaceuticalsVaxcyte, Inc. · patent 12,121,575 granted from it
Apr 25, 20242024/0131134PERIODONTITIS VACCINE AND RELATED COMPOSITIONS AND METHODS OF USEPharmaceuticalsVaxcyte, Inc. · patent 12,121,575 granted from it
Jan 4, 20242024/0000926PURIFICATION PROCESSES FOR POLYSACCHARIDES AND POLYPEPTIDE CONJUGATES THEREOFPharmaceuticalsVaxcyte, Inc.
Sep 21, 20232023/0293658GROUP A STREP IMMUNOGENIC COMPOSITIONS WITH POLYSACCHARIDE-PROTEIN CONJUGATESPharmaceuticalsVaxcyte, Inc.
Jun 15, 20232023/0183147CARRIER-PROTEIN POLYSACCHARIDE CONJUGATION METHODSPharmaceuticalsVaxcyte, Inc. · patent 12,252,454 granted from it
What it applied for, 2024 to 2025: Pharmaceuticals 8.

A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.

SI Assistanton PCVX · research, not advice